Literature DB >> 30374241

Extracorporeal Membrane Oxygenation in a 29-Year-Old Man with Pneumocystis jirovecii Respiratory Failure and AIDS.

Antonio T Hernandez Conte, David Ng, Danny Ramzy, Deanna Dilibero, Troy M LaBounty, Cyril Gaultier, Elizabeth C Behringer.   

Abstract

The use of extracorporeal membrane oxygenation (ECMO) in patients who have acute respiratory distress syndrome has been generally beneficial. However, because of various concerns, ECMO has rarely been used in patients who have human immunodeficiency virus infection with or without acquired immune deficiency syndrome. We report our successful use of venovenous ECMO in a 29-year-old man who presented with severe respiratory distress secondary to Pneumocystis jirovecii pneumonia associated with undiagnosed infection with the human immunodeficiency virus and acquired immune deficiency syndrome. After highly active antiretroviral therapy was begun, acute immune reconstitution inflammatory syndrome developed. The patient's respiratory condition deteriorated rapidly; he was placed on venovenous ECMO for 19 days and remained intubated thereafter. After a 65-day hospital stay and inpatient pulmonary rehabilitation, he recovered fully. In addition to presenting this case, we review the few previous reports and note the multidisciplinary medical and surgical support necessary to treat similar patients.

Entities:  

Keywords:  Antiretroviral therapy, highly active/methods/therapeutic use; HIV infections/complications/diagnosis/drug therapy/physiopathology; extracorporeal membrane oxygenation/methods; immune reconstitution inflammatory syndrome/complications/therapy; pneumonia, pneumocystis/complications/physiopathology/prevention & control; treatment outcome

Mesh:

Year:  2018        PMID: 30374241      PMCID: PMC6183642          DOI: 10.14503/THIJ-16-6186

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  20 in total

1.  Survival of persons with and without HIV infection in Denmark, 1995-2005.

Authors:  Nicolai Lohse; Ann-Brit Eg Hansen; Gitte Pedersen; Gitte Kronborg; Jan Gerstoft; Henrik Toft Sørensen; Michael Vaeth; Niels Obel
Journal:  Ann Intern Med       Date:  2007-01-16       Impact factor: 25.391

2.  2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention.

Authors:  Charanjit S Rihal; Srihari S Naidu; Michael M Givertz; Wilson Y Szeto; James A Burke; Navin K Kapur; Morton Kern; Kirk N Garratt; James A Goldstein; Vivian Dimas; Thomas Tu
Journal:  J Am Coll Cardiol       Date:  2015-04-07       Impact factor: 24.094

Review 3.  Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART.

Authors:  Matthias Stoll; Reinhold E Schmidt
Journal:  Curr HIV/AIDS Rep       Date:  2004-09       Impact factor: 5.071

4.  Respiratory failure from severe Pneumocystis carinii pneumonia. Entering the third era.

Authors:  R M Wachter; J M Luce
Journal:  Chest       Date:  1994-11       Impact factor: 9.410

Review 5.  The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.

Authors:  Edward M Gardner; Margaret P McLees; John F Steiner; Carlos Del Rio; William J Burman
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

6.  Successful extracorporeal lung assistance for overwhelming pneumonia in a patient with undiagnosed full blown aids--a controversial therapy in HIV-patients.

Authors:  H Gutermann; B van Roy; W Meersseman; B Meyns; P Herijgers
Journal:  Thorac Cardiovasc Surg       Date:  2005-08       Impact factor: 1.827

7.  Immune Restoration Inflammatory Syndromes: The Dark Side of Successful Antiretroviral Treatment.

Authors:  Matthias Stoll; Reinhold E. Schmidt
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

8.  Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors.

Authors:  Hou-Hsien Chiang; Chien-Ching Hung; Chang-Min Lee; Hsuan-Yu Chen; Mao-Yuan Chen; Wang-Huei Sheng; Szu-Min Hsieh; Hsin-Yun Sun; Chao-Chi Ho; Chong-Jen Yu
Journal:  Crit Care       Date:  2011-08-26       Impact factor: 9.097

Review 9.  Extra corporeal membrane oxygenation to facilitate lung protective ventilation and prevent ventilator-induced lung injury in severe Pneumocystis pneumonia with pneumomediastinum: a case report and short literature review.

Authors:  Husain Shabbir Ali; Ibrahim Fawzy Hassan; Saibu George
Journal:  BMC Pulm Med       Date:  2016-04-14       Impact factor: 3.317

10.  HIV-related Pneumocystis jirovecii pneumonia managed with caspofungin and veno-venous extracorporeal membrane oxygenation rescue therapy.

Authors:  Nathaniel Lee; David Lawrence; Brijesh Patel; Stephane Ledot
Journal:  BMJ Case Rep       Date:  2017-10-04
View more
  2 in total

1.  Protective effect of extracorporeal membrane oxygenation on intestinal mucosal injury after cardiopulmonary resuscitation in pigs.

Authors:  Yong Liang; Chunsheng Li; Bo Liu; Qiang Zhang; Xiaoli Yuan; Yun Zhang; Jiyang Ling; Lianxing Zhao
Journal:  Exp Ther Med       Date:  2019-10-08       Impact factor: 2.447

2.  Successful Extracorporeal Membrane Oxygenation Treatment in an Acquired Immune Deficiency Syndrome (AIDS) Patient with Acute Respiratory Distress Syndrome (ARDS) Complicating Pneumocystis jirovecii Pneumonia: A Challenging Case.

Authors:  Benedetto Maurizio Celesia; Andrea Marino; Savino Borracino; Antonio F Arcadipane; Grazia Pantò; Maria Gussio; Salvatore Coniglio; Alfio Pennisi; Bruno Cacopardo; Giovanna Panarello
Journal:  Am J Case Rep       Date:  2020-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.